Italy is definitely a high-risk country for multiple sclerosis (MS). Over the last 50 years,
several epidemiological studies, including longitudinal surveys, have disclosed that MS …

Objective To describe the pattern of development of incidence of multiple sclerosis (MS)
over 60 years in Denmark with age-period-cohort analyses and seasonality of birth. Methods …

Natalizumab (Nat) is a humanized monoclonal antibody used for the treatment of relapsing
multiple sclerosis (MS). Nat inhibits lymphocyte migration via the blood brain barrier (BBB) …

Italy is a high risk area for multiple sclerosis (MS) as confirmed by the numerous prevalence
and incidence studies conducted in several regions/districts of the country. Nevertheless …

Multiple sclerosis is characterized by a non-homogeneous distribution around the world.
Some authors in past described a latitude gradient, with increasing risk from the equator to …

Background: Incidence and prevalence trends of multiple sclerosis (MS) in the Province of
Padua, North-East Italy, suggest that environmental factors may be associated with …

Compared with other areas of the country, very limited data are available on multiple
sclerosis (MS) prevalence in Central Italy. We aimed to estimate MS prevalence in the Lazio …

Introduction Multiple sclerosis (MS) is an autoimmune disease of the CNS, which
predominantly affects women. Studies investigating the sex distribution in MS are sparse …

Multiple Sclerosis (MS) is a chronic debilitating disease of probable autoimmune
inflammatory nature, whose aetiology is not fully understood, despite the many efforts and …

Background: Multiple Sclerosis (MS) epidemiology in Italy is mainly based on population-
based prevalence studies. Administrative data are an additional source of information, when …